Sign inJoin waitlistJoin the waitlist

Cristina Truica

Director of Breast Medical Oncology · Penn State Milton S Hershey Medical Center

Credentials: · · · ·

History

Penn State Milton S Hershey Medical Center
Present

MedStar Georgetown University Hospital
1995–1998
Internal Medicine
York Hospital
1993–1995
Jersey City Medical Center
1992–1993
Internal Medicine University Hospital C Davila
1991–1992
University of Medicine & Pharmacy Carol Davila
1985–1989

Research

Acoustic separation of circulating tumor cells
Proceedings of the National Academy of Sciences of the United States of America · 2015 · 464 citations
Beta-catenin mutations in human prostate cancer
Cancer Research · 1998 · 319 citations
Beta-catenin affects androgen receptor transcriptional activity and ligand specificity
Cancer Research · 2000 · First of 3 authors · 296 citations

Joseph Drabick
6 papers
Wafik El-Deiry
4 papers
Christopher Sciamanna
3 papers
Nicholas Lamparella
3 papers · 1 as a fellow
Aditya Joshi
2 papers
BR
Bhuvaneswari Ramaswamy
2 papers
DN
Darya Nesterova
2 papers
Edward Gelmann
2 papers
EM
Elizabeth Matthew
2 papers
Erika Saunders
2 papers
Joseph Sparano
2 papers
LC
Leah Cream
2 papers

Clinical trials

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2026–2029
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2025–2037
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Site PI · Recruiting · Phase 3
Stemline Therapeutics, Inc.
2024–2032
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2023–2033